Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study (Q37481863)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study |
scientific article |
Statements
1 reference
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study (English)
1 reference
H S Friedman
1 reference
D D Bigner
1 reference
A Desjardins
1 reference
D A Reardon
1 reference
J J Vredenburgh
1 reference
S Gururangan
1 reference
J H Sampson
1 reference
S Sathornsumetee
1 reference
R E McLendon
1 reference
J E Herndon
1 reference
J E Marcello
1 reference
J Norfleet
1 reference
A H Friedman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference